Water Vapor Thermal Therapy for the Treatment of Benign Prostatic Hyperplasia
Last updated on July 16, 2024Health Technology Assessment
The Health Technology Assessment Committee commissioned a health technology assessment for the review of water vapor thermal therapy for the treatment of benign prostatic hyperplasia.
The assessment includes a systematic review of the clinical and economic evidence, a jurisdictional scan to determine how Rezum is offered across Canadian provinces and territories, and a summary of key stakeholder and clinician experiences. The full assessment can be viewed here.